The Valley Desk

ArticleDrug, healthcare and patient safetyPublished

Comparing Out-of-Pocket Costs and Health-Related Quality of Life Between Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
Drug, healthcare and patient safety
Published
Subject terms
Health-related Quality Of Life; Health Care Expenditure; Sglt2 Inhibitor; Glp-1 Receptor Agonist; Medical Expenditure Panel Survey
PubMed ID
40302900
PubMed Central ID
PMC12039827
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal